I.R. APIXABAN 2,5 mg and 5 mg tablets (Product under development)

Products

Information

Anticoagulant (blood thinner) that reduces blood clotting and reduces the risk of stroke and systemic embolism in patients with nonvalvular atrial fibrillation.
All categories
Finished Dosage FormsTabletsProducts
Main Categories
Finished Dosage Forms
Valpharma International SpASince more than 40 years, VALPHARMA has been specialized in the development and contract manufacture of modified release products in capsules (hard-soft) and tablets, with own technology, supplying them to pharmaceutical companies worldwide. Its own R&D Department develops annually many new products in modified release form with own patents, changing posology from three or more daily dosings into once-twice daily dosing, optimizing pharmaceutical effects and reducing side-effects. Authorized by the Italian, Brazilian, Iranian, Ivory Coast, Japanese, Turkish, Taiwanese and United Arab Emirates ...

Log in

See all the content and easy-to-use features by logging in or registering!